StopUMTS Logo
how to get rid of moles 
Zoeken
   
Voorlichting
19/04/18Metaalkeuze ter behoeve v
08/03/18Boeken over EMV / stralin
Artikelen
21/04/18Report on National Toxico
20/04/18COMPILATIE: Maatregelen v
20/04/18Vaccins: International sc
19/04/18Scientific Research On 5G
16/04/18Deadly common combo produ
13/04/18Can Cell Phones Cause Fem
Berichten Nederland
21/04/18It’ers breken via web i
21/04/18Grote groei mobiele netwe
20/04/18Gezondheidsraad: Hoogspan
19/04/18Lezing: Smartphones, WiFi
19/04/18Informatieavond over zend
Berichten België
03/04/18Teken de petitie tegen ve
29/03/18Huidkanker: “België he
Berichten Internationaal
19/04/18Huawei boss warns the pot
17/04/18Bulging Debt May Spell Tr
15/04/18Huidkanker: Incidentie in
13/04/18French Telecom Operator O
Ervaringen | Appellen/oproepen
20/04/18Skin Cancer, Cell phones
14/04/18Video over straling thuis
11/04/185G en LED verlichting; sl
Onderzoeken
13/04/18Electromagnetic radiation
11/04/18Semi-quantitative proteom
26/03/18Aggressive Brain Tumors o
Veel gestelde vragen
13/05/17Vakantie? Witte zo
10/07/16Zeven veel gestelde vrage
Juridische informatie
02/03/18Formal Complaint to the E
26/02/185G From Space & Santa Fe
23/01/18Reeks publicaties op juri
Oproepen
19/04/18Lezing: Smartphones, WiFi
07/04/18EHS Uitnodiging landelijk
29/03/18Bijeenkomst Klankbordgroe
Folders
10/09/17Brochures, folders, websi
29/04/16USA: Meer dan 50 tips voo
Briefwisselingen | Archief: 2008, 2005
05/04/18Brief naar Monique Beerla
04/04/18Volkskrant: e-mail naar d
Illustraties
 Algemeen
 Fotoalbum zendmasten
 Wetenschappelijke illustraties
Changing incidence and improved survival of gliomas    
Ga naar overzicht berichten in: Onderzoeken

Changing incidence and improved survival of gliomas
woensdag, 23 juli 2014 - Dossier: Algemeen


Bron: www.ejcancer.com/article/S0959-8049(14)00718-7/abstract .
24 juni 2014


Vincent K.Y. Hoemail, Jaap C. Reijneveld, Roelien H. Enting, Henri P. Bienfait, Pierre Robe, Brigitta G. Baumert, Otto Visser, On behalf of the Dutch Society for Neuro-Oncology (LWNO)
Received: January 27, 2014; Received in revised form: May 21, 2014; Accepted: May 21, 2014; Published Online: June 24, 2014

Abstract
Background
Tumours of the central nervous system (CNS) represent a relatively rare but serious health burden. This study provides insight into the incidence and survival patterns of gliomas in the Netherlands diagnosed in adult patients during the time period 1989–2010, with a focus on glioblastoma and low-grade gliomas.

Methods
Data on 21,085 gliomas (excluding grade I tumours) were obtained from the Netherlands Cancer Registry, including tumours of the CNS without pathological confirmation. We calculated the age-standardised incidence rates and the estimated annual percentage change (EAPC) for all glioma subtypes. Crude and relative survival rates were estimated using information on the vital status obtained from the Dutch Municipal Personal Records Database.

Results
Incidence of gliomas in adults increased over time, from 4.9 per 100,000 in 1989 to 5.9 in 2010 (EAPC 0.7%, p < 0.001). Two thirds were astrocytoma, 10% oligodendroglioma/oligoastrocytoma, 3% ependymoma and 21% were unspecified. Within the group of astrocytic tumours, the proportion of glioblastoma rose, while the proportion of anaplastic and unspecified astrocytoma decreased. Unspecified neoplasms also decreased, but this was significant only after 2005. Over the course of the study period, glioblastoma patients more often received multimodality treatment with chemotherapy concomitant and adjuvant to radiotherapy. The crude two-year survival rate of glioblastoma patients improved significantly, from 5% in the time period 1989–1994 to 15% in 2006–2010, with median survival increasing from 5.5 to 9 months. The incidence of low-grade gliomas did not change over time. Survival rates for low-grade oligodendroglial and mixed tumours show a modest improvement.

Conclusions
The incidence rate for the total group of gliomas slightly increased, with a decrease of anaplastic and unspecified tumours and an increase of glioblastoma. Following the introduction of combined chemoradiation, two-year survival rates for glioblastoma significantly improved. Survival improved for low-grade gliomas except for low-grade astrocytic tumours.

Keywords:
Glioma, Glioblastoma, Astrocytoma, Oligodendroglioma, Oligoastrocytoma, Ependymoma, Central nervous system, Incidence, Survival


Ga terug naar het hoofdmenu
Afdrukken | Vragen | RSS | Disclaimer